Rapid initiation of antiretroviral therapy in Turkey: a modeling study
Frontiers in Public Health · 26.01.2024 · 12
DOI: 10.3389/fpubh.2024.1224449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 26.01.2024. Verfasst von Emine Yaylali und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial Engineering, Istanbul Technical University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Background
To effectively control the HIV epidemic and meet global targets, policymakers recommend the rapid initiation of antiretroviral therapy (ART). Our study aims to investigate the effect of rapid ART programs on individuals diagnosed with HIV, considering varying coverage and initiation days after diagnosis, and compare it to standard-of-care ART treatment in Turkey.
Methods
We used a dynamic compartmental model to simulate the dynamics of HIV infection in Turkey. Rapid treatment, defined as initiation of ART within 7 days of diagnosis, was contrasted with standard-of-care treatment, which starts within 30 days of diagnosis. This study considered three coverage levels (10%, 50%, and 90%) and two rapid periods (7 and 14 days after diagnosis), comparing them to standard-of-care treatment in evaluating the number of HIV infections between 2020 and 2030.
Results
Annual HIV incidence and prevalence for a 10-year period were obtained from model projections. In the absence of a rapid ART program, the model projected approximately 444,000 new HIV cases while the number of cases were reduced to 345,000 (22% reduction) with 90% of diagnosed cases included in the rapid ART program. Similarly, 10% and 50% rapid ART coverage has resulted in 3% and 13% reduction in HIV prevalence over a 10-year period.
Conclusion
Rapid ART demonstrates the potential to mitigate the increasing HIV incidence in Turkey by reducing the number of infections. The benefit of the rapid ART program could be substantial when the coverage of the program reaches above a certain percentage of diagnosed population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Industrial Engineering, Istanbul Technical University, Istanbul, Türkiye.
- Infectious Diseases, Ege University, Izmir, Türkiye.
- Infectious Diseases and Clinical Microbiology, Akdeniz Yasam Hospital, Antalya, Türkiye.
- Infectious Diseases and Clinical Microbiology, Haydarpasa-Numune Training and Research Hospital, Istanbul, Türkiye.
- Infectious Diseases and Clinical Microbiology, University of Health Sciences, Istanbul, Türkiye.
- Infectious Diseases and Clinical Microbiology, Koc University, Istanbul, Türkiye.
Förderung
- Gilead Sciences
Zitieren
APA
Yaylali, E., Erdogan, Z. M., Calisir, F., Pullukcu, H., Yildirim, F., Inan, A., Aydin, O. A., Tekin, S., Sonmezer, M. C., Sahin, T., Ozcagli, T. G., & Ozelgun, B. (2024). Rapid initiation of antiretroviral therapy in Turkey: a modeling study. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1224449
Vancouver
Yaylali E, Erdogan ZM, Calisir F, Pullukcu H, Yildirim F, Inan A, et al. Rapid initiation of antiretroviral therapy in Turkey: a modeling study. Frontiers in Public Health. 2024;12. doi:10.3389/fpubh.2024.1224449
BibTeX
@article{Yaylali2024,
author = {Yaylali, Emine and Erdogan, Zikriye Melisa and Calisir, Fethi and Pullukcu, Husnu and Yildirim, Figen and Inan, Asuman and Aydin, Ozlem Altuntas and Tekin, Suda and Sonmezer, Meliha Cagla and Sahin, Toros and Ozcagli, Tahsin Gokcem and Ozelgun, Berna},
title = {Rapid initiation of antiretroviral therapy in Turkey: a modeling study},
journal = {Frontiers in Public Health},
year = {2024},
volume = {12},
doi = {10.3389/fpubh.2024.1224449}
}
EUVIMED